Introduction
Angina pectoris is caused by rapid, transient myocardial ischemia and hypoxia. 1 It is generally acknowledged that patients with angina pectoris have the risk of acute myocardial infarction (AMI) and sudden death, and the prognosis depends on the extent of coronary artery disease and heart function. 1 The incidence of angina in China has increased year by year. 2, 3 Moreover, the onset age has become much younger. 4 Although the etiology of coronary heart disease (CHD) remains indistinct, the cause of CHD is believed to be multifactorial. The recommended risk factors include: systematic conditions, such as diabetes mellitus, hyperlipidemia, [5] [6] [7] hypertension 8, 9 ; the inflammatory biomarkers: hs-CRP 10, 11 ; habits and customs: cigarette 12, 13 and alcohol. 14 TCM also has records on this subject. Angina pectoris belongs to the category of chest obstruction in TCM. It is believed that the occurrence of the disease has been associated with the invasion of pathogenic cold, eating disorder, emotional illness, etc. 15 Eating lot of greasy and sweet food or being addicted to cigarette and alcohol may lead to dysfunction of the spleen. 15 So that phlegm retention is gathered by the water and dampness. In TCM, the concept of phlegm is referred to as the resultant of metabolic disorders of the body's water. This pathological product may block blood circulation, influence the function of organs, and cause a variety of complex pathological changes in the body, thus leading to the emergence of phlegm syndrome. Phlegm syndrome refers to the symptoms caused by the stopping of phlegm. Phlegm blocks the arteries and veins of heart, which ultimately leads to phlegm syndrome causing chest obstruction. 15 Hyperlipidemia has been investigated to be associated with phlegm syndrome of angina pectoris, but the consequences are contradictory. Despite the fact that these biomarkers were found to significantly increase the risk of phlegm syndrome of angina pectoris in some studies, [16] [17] [18] [19] [20] [21] [22] [23] [24] others found only borderline relationship or even no association. 25, 26 Therefore, we established this systematic review to further examine the relationship between blood lipid with phlegm syndrome of angina pectoris.
Methods

Protocol and registration
Our protocol can be accessed on University of York Centre for Reviews and Dissemination (http://www.crd.york.ac.uk/ prospero/), the registration number is: CRD42013006687.
Search methods
Data sources
According to the ''Cochrane Handbook for Systematic Reviews of Interventions'' published by The Cochrane Collaboration, we screened the following online databases along with manual screening: China National Knowledge 
Search strategies
The following terms: ''Coronary heart disease,'' ''angina,'' ''phlegm,'' ''phlegm syndrome'' were used to identify all relevant studies. When screening ScienceDirect and other English databases, we built a search strategy as follows: (a) angina; (b) phlegm syndrome; (c) phlegm Zheng; (d) phlegm pattern; (e) tan zhuo; (f) a in all fields; (g) b in all fields; (h) c in all fields; (i) d in all fields (j) e in all fields; (k) g 'OR' h 'OR' i 'OR' j 'AND' f. For CNKI and other Chinese databases the following strategy was used: (a) CHD; (b) angina; (c) phlegm; (d) a in abstract; (e) b in abstract; (f) c in abstract; (e) d 'OR' e 'AND' f.
Selection criteria
Eligible research should meet the following criteria: (a) case-control studies; (b) participants should be diagnosed with angina pectoris (stable and unstable) in Western medicine and chest obstruction in TCM; (c) phlegm syndrome should be contained; (d) diagnosis standard must be authoritative (''authoritative'' means the diagnosis standard should be acknowledged universally or generally approved over the country, which is showed in Table 1) ; (e) providing sufficient data for standardized mean difference (SMD) with the corresponding 95% confidence interval (CI); (f) investigating the association between blood lipid and phlegm syndrome of chest obstruction.
Exclusion criteria
The exclusion criteria were: (a) no control group set in the documents, (b) unclear original data, (c) no clearly identified result assessment, (d) patients with acute coronary syndrome (ACS), (e) unclear or overlapping TCM syndrome type, (f) no comparison between TCM syndromes, and (g) multiple contributions of one manuscript.
Data collection and analysis
Data extraction and management
After ruling out unsatisfactory literature through screening the title and abstract, two reviewers then read the full text to assess the inclusion standards independently. Any disagreement was resolved through discussion or third-party opinions on the basis of a cross-check.
One reviewer took a standardized electronic data collection form to extract data while a subsequent reviewer checked the accuracy separately. When necessary, additional information was sought from first or corresponding authors via electronic mail.
The phlegm turbidity group was considered as the experimental group and was compared with the non-phlegm turbidity group which was considered as the control group. We found that the non-phlegm turbidity group was divided into subgroups such as blood stasis syndrome, qi stagnation syndrome (QSS), qi deficiency syndrome, and other syndromes to collect data in most studies. In some articles, original data could not be obtained even after contacting the authors. Therefore, the mean value and standard deviation value for each subgroup of these studies were combined to get an incorporated mean value and standard deviation value. The derived formula is calculated by formula (a) and formula (b).
27,28
Assessment of risk of bias in included studies
According to Cochrane Review's Handbook 5.0.1 29 and evaluation standard of case-control study suggested by Wells G., 30 we used ''Newcastle-Ottawa Quality Assessment Scale: Case Control Studies'' (NOS) to assess the quality of included studies in items such as selection of study groups, comparability of their cases and controls, and the exposure on cases and controls. When conforming to the criteria for an item, a study would get one star and result in a maximum nine stars. Studies that received more than six stars were considered as high quality, analogous to other reviews. 31, 32 We specifically classified studies at elevated risk of bias (1-3 stars), intermediate risk of bias (4-5 stars), or low risk of bias(6-9 stars). As this study focused on the phlegm syndrome of angina, we explained the ''no history of disease (endpoint)'' item as ''no history of phlegm turbidity symptom of angina pectoris.'' Furthermore, we created a funnel plot to analyze potential publication bias.
Data synthesis
The Revman 5.2.6 software provided by ''The Cochrane Collaboration'' was used to analyze the collected data. SMD with its 95% CI were used to assess the association between biomarkers and the phlegm syndrome of angina. Heterogeneity was assessed by the Q-statistic test and I 2 statistic. 33 Inter-studies heterogeneity was considered to be significant under the condition of P value <0.05 with I 2 value >50%. 34 When heterogeneity was absent, a fixed-effects model of the inverse variance method was used to calculate pooled SMD. Otherwise, a random-effects model was taken.
Subgroup analysis and investigation of heterogeneity
The subgroup analysis was established according to the sample size proportion between the test group and the control group (T/C > 1/4 vs. T/C < 1/4). And the between-studies heterogeneity was investigated through reevaluation of the original literature and data. Initially, we planned to explore population-level variables: geographic latitude (north vs. south) and the mean age; and then the following studylevel variables were investigated: year, total sample size, sample size of the experimental group, sample size of the control group, angina type (stable vs. unstable vs. both), different diagnostic criteria of angina pectoris, number of TCM syndrome, the characteristic of TCM syndrome (deficiency syndrome vs. sthenia syndrome), type of TCM syndrome (e.g., QSS, blood stasis syndrome, qi deficiency syndrome, and so on). When necessary, the sub-subgroup analysis was built on the basis of probable resource of heterogeneity caused by different syndromes contained in the non-phlegm turbidity group.
Sensitivity analysis
To inspect the stability of the results, sensitivity analysis was constructed by using two different effect models.
Results
Results of the search
Totally, 2152 references were retrieved, among which 2047 were in Chinese and 105 in English. After ruling out the articles that were obviously unrelated to the study and repeated ones, 75 were left, including two in English. Among them, 64 articles were excluded through intensive screening for not meeting the inclusion criteria. This systematic review eventually yielded 11 original documents, all in Chinese (Table 2 ). Fig. 1 shows the process of study selection.
Risk of bias in included studies
We assumed studies that received more than six stars on the NOS criteria to be of high quality. The average value of the included studies was seven stars indicating superior quality evidence (Table 3) .
Exposure results
The exposure results are pooled in Table 4 .
Contained TCM syndromes list
TCM syndromes involved in the non-phlegm turbidity group are pooled in Table 5 .
Triglyceride
The outcome showed that the ''T/C > 1/4 subgroup'' had significant heterogeneity (X 2 : 145.13, df: 7, P > 0.00001, I 2 : 95%). We discovered that the difference of the non-phlegm turbidity group composition in these studies [16] [17] [18] 20, 21, 23, 25, 26 was distinct from reviewing of the original data and thus divided studies into two sub-subgroups: Yang defi- 
Total cholesterol
For ''T/C < 1/4 subgroup,'' 22,24 the SMD manifested that total cholesterol (TC) levels in the test group was higher compared with the control group in Fig. 3 (SMD: 0.62, 95% CI: 0.32-0.91). The heterogeneity evaluation turned out to be significant in the ''T/C > 1/4 subgroup'' (X 2 : 99.66, df: 8, P > 0.00001, I
2 : 92%). The sub-subgroup analysis was completed in accordance with YDS comprised. For ''YDS included in T/C > 1/4 subgroup,'' 18,20 heterogeneity concluded to be remarkable (X 2 : 14.03, df: 1, P: 0.0002, I 2 : 93%) so as to random-effects model was used (Fig. 4) .
The heterogeneity of ''non-YDS included in T/C > 1/4 subgroup'' 16, 17, 19, 21, 23, 25, 26 also turned out to be significant (X 2 : 17.28, df: 6, P: 0.008, I
2 : 65%). Hence, the studies were divided in terms of whether Qi and yin deficiency syndrome (QYDS) was contained. As is shown in Fig. 5 , the TC levels in test group were higher than that in control group in ''QYDS included in non-YDS group'' (SMD: 0.61, 95% CI: 0.35-0.87); 
Low-density lipoprotein-cholesterol
Additionally, sub-subgroup analysis was accomplished according to ''YDS included in T/C > 1/4 subgroup'' and ''non-YDS included in T/C > 1/4 subgroup'' on account of the significant heterogeneity (X 2 : 46.80, df: 7, P > 0.00001, I 2 : 85%). For non-YDS included subgroup, the subset analysis was performed in that whether the QYDS was contained because of significant heterogeneity (X 2 : 14.69, df: 3, P: 0.002, I
2 : 80%; X 2 : 17.36, df: 5, P: 0.004, I 2 : 71%). Lowdensity lipoprotein-cholesterol (LDL-C) levels in the test group proved to be exceeding that of the control group in subgroups except for the ''non-QYDS in non-Yang deficiency'' sub-subgroup (SMD: 0.12, 95% CI: −0.13-0.37) from 
High-density lipoprotein-cholesterol
It is shown in Fig. 6 that the middle line intersects the diamond of the T/C < 1/4 subgroup (SMD: −0.26, 95% CI: −0.55-0.03). Heterogeneity of ''T/C > 1/4 subgroup'' proved to be significant (X 2 : 25.80, df: 7, P: 0.0005, I 2 : 73%) and consequently lead to further sub-subgroup analysis demonstrated in line with whether YDS was embraced. The SMDs indicated that high-density lipoprotein-cholesterol (HDL-C) levels in the test group was lower than that in the 
Sensitivity analysis
The Random effects model was used to evaluate the studies, as is provided in Table 6 . Taking different diagnostic criteria of angina pectoris in consideration, we play sensitivity analysis through removing a study which has different diagnostic criteria with others in the same subgroup as well. The result showed no significant difference and is presented in Table 7 .
Publication bias assessment
As is shown in Figs. 7 and 8 , the funnel graphic is almost symmetrical, suggesting no publication bias of the included studies. Qi and yin deficiency syndrome; HKYIDS: heart kidney-yin deficiency syndrome; HKYADS: heart kidney-yang deficiency syndrome; YDS: Yang deficiency syndrome; QDBS: Qi deficiency and blood stasis; FAHS: syndrome of fire attacking the heart; HBSS: heart blood stasis syndrome; HQDS: heart Qi deficiency syndrome. ''+'' means included; '−' means not included. 
Discussion
For TG, only the diamond of the non CCS-non YDS subgroup 17, 23, 25 passed through the median line, indicating that TG level in the experimental group and the control group showed no statistical difference. However, TG levels in the phlegm syndrome group were higher compare with the non-phlegm syndrome group in the rest of the subgroups. No statistically meaningful difference existed between the test group and control group for TC and LDL-C levels in non-QYDS-non-YDS subgroup, whereas the two biotic indicators in the test group were higher than that in the non-phlegm syndrome group in other subgroups. By reading primeval literature, we found that the non-phlegm syndrome group of these studies was consisted by QSS, heart blood stasis syndrome (HBSS), and CCS. This result declared that when comparing with these TCM syndromes with sthenia nature, no obvious difference was shown for TG, TC, and LDL-C levels. Nevertheless, for asthenia syndromes such as YDS, QYDS, and HQDS, the difference proved to be significantly obvious. Furthermore, HDL-C levels of the phlegm group were lower than that of non-phlegm group in all subgroups. In this study, we regarded phlegm syndrome as the test group and took non-phlegm syndrome as the control group. The non-phlegm syndrome group included a variety of TCM syndromes. Thus, in order to ensure the integrity of the data, we apply the translated formula to calculate the combined mean value and standard deviation value. After the combination, the case number in the control group was significantly greater than that of the control group. According to the individual matching principle of the case-control study, 35 it makes slight sense to effect which the proportion between the case number of the test group and control group less than 1/4(T/C < 1/4). Therefore, subgroup analysis was carried out according to the case number proportion. The NOS scale was utilized to appraise the quality of the researches, and the score was seven stars in all studies, thus indicating that the results of this study had credibility to some extent.
What's new: The systematic review focus on risk factors of angina pectoris has already existed, well meta-analysis on risk factors of certain TCM syndrome of angina pectoris has not yet. A number of studies on risk factors for TCM syndromes of CHD have existed, [36] [37] [38] but no with consensus. Moreover, the systematic review about this topic is unprecedented. It is acknowledged that phlegm turbidity is the pathological production due to spleen deficiency and dysfunctional transportation of the moisture. 15 Patients with phlegm turbidity syndrome were obese and physically heavy and sleepy, which is similar to patients with hyperlipidemia. In recent years, more and more studies have investigated the treatment of CHD from the perspective of strengthening spleen and removing phlegm which showed a noteworthy effect. [39] [40] [41] Blood lipids as the customary risk factors for CHD have been widely recognized. This study explored the correlations between blood lipids and phlegm syndrome of CHD hoping for offer corroborative evidence for the theory of treating CHD through adjusting the spleen function from the view of etiology.
The theory of ''treating before disease attack'' in TCM coincides with modern preventive medicine. This study explored risk factors for the phlegm syndrome of CHD and provided new ideas for the prevention of CHD in a sense. If prevention and treatment can be earlier undertaken based on the risk factors, as the theory always emphasized in TCM--treating before disease attack, the results of our study might have profound clinical and public health significance.
Limitation
This study has several limitations. First, the measuring instruments of the biomarkers in these studies cannot be guaranteed to be exactly the same, therefore, methodological heterogeneity might be caused by different tools. 42 Second, the mean value and standard deviation value of the control group were translated according to the formula on account of first-hand data not obtainable, which may cause bias. Third, the effect is not meaningful for studies of which the case number proportion is <1/4(T/C < 1/4). Last but not the least, even though we searched the authoritative English database, no English studies met the inclusion criteria were collected eventually. Therefore publication bias may exist.
Conclusion
The levels of TG, TC, and LDL-C were demonstrated to be higher in phlegm turbidity syndrome when compared with TCM syndromes with asthenia nature such as YDS, QYDS, and HQDS. However, for sthenia syndromes such as QSS, HBSS, and CCS, there was no obvious difference. Moreover, HDL-C levels of the phlegm turbidity group were lower than that of the non-phlegm group. Nonetheless, these results should be confirmed with further studies.
